What is LOPJLB’s current signal on ATRA?

LOPJLB’s latest quantitative signal on Atara Biotherapeutics, Inc. (ATRA) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is ATRA in?

Atara Biotherapeutics, Inc. (ATRA) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Atara Biotherapeutics, Inc. (ATRA) do?

Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3…